Johnson & Johnson (JNJ) settled lawsuits with about 845 plaintiffs who claimed the drugmaker didn’t properly warn of the risks of tendon damage from its antibiotic Levaquin.
The settlements were disclosed in an Oct. 30 filing in federal court in Minneapolis, where a judge is overseeing about 1,900 Levaquin lawsuits. The initial agreements will be completed in the next two weeks, the plaintiffs said in the filing, which didn’t say how much Johnson & Johnson would pay.
The settlements were disclosed in an Oct. 30 filing in federal court in Minneapolis, where a judge is overseeing about 1,900 Levaquin lawsuits. The initial agreements will be completed in the next two weeks, the plaintiffs said in the filing, which didn’t say how much Johnson & Johnson would pay.
